091990 — Celltrion Healthcare Co Balance Sheet
0.000.00%
Last trade - 00:00
HealthcareAdventurousLarge Cap
- KR₩12tn
- KR₩12tn
- KR₩2tn
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS/A | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 571,077 | 457,587 | 527,189 | 524,905 | 530,191 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 448,218 | 549,230 | 847,621 | 977,397 | 1,220,821 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,793,377 | 2,666,271 | 3,498,862 | 3,702,742 | 4,275,666 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 362 | 2,394 | 6,211 | 7,116 | 9,416 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 2,948,569 | 2,848,905 | 3,739,698 | 3,914,694 | 4,454,599 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,279,135 | 1,071,072 | 1,657,774 | 1,644,213 | 2,244,902 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,313,091 | 1,183,011 | 1,806,769 | 1,808,927 | 2,392,807 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 1,635,478 | 1,665,894 | 1,932,930 | 2,105,768 | 2,061,791 |
Total Liabilities & Shareholders' Equity | 2,948,569 | 2,848,905 | 3,739,698 | 3,914,694 | 4,454,599 |
Total Common Shares Outstanding |